|Day's Range||21.15 - 21.50|
|52 Week Range||18.16 - 22.24|
|PE Ratio (TTM)||48.29|
|Dividend & Yield||0.95 (5.02%)|
|1y Target Est||N/A|
Celldex Therapeutics and Agenus have promising oncology pipelines, but which is the better stock right now?
Ionis Pharmaceuticals, Inc. (IONS) announced that the phase III study NEURO-TTR on inotersen (IONIS-TTRRx) in patients with familial amyloid polyneuropathy (FAP) met both primary endpoints.
Shares of Pfizer Inc. (NYSE: PFE ) were trading lower by nearly 2 percent Tuesday morning after analysts at Citi downgraded the stock and offered three alternative recommendations. Citi's Andrew Baum downgraded ...